Novo A/S as of June 30, 2016
Portfolio Holdings for Novo A/S
Novo A/S holds 18 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Vanguard Total Stock Market ETF (VTI) | 24.2 | $231M | 2.2M | 107.16 | |
Ophthotech | 19.3 | $184M | 3.6M | 51.03 | |
Inogen (INGN) | 18.7 | $178M | 3.5M | 50.11 | |
Vanguard European ETF (VGK) | 10.3 | $98M | 2.1M | 46.66 | |
Reata Pharmaceuticals Inc Cl A | 7.0 | $67M | 3.4M | 19.75 | |
Corvus Pharmaceuticals (CRVS) | 4.8 | $46M | 3.2M | 14.26 | |
Tobira Therapeutics Inc Common Stock Usd 0.0001 | 2.7 | $26M | 2.0M | 12.56 | |
Colucid Pharmaceuticals | 2.6 | $25M | 3.1M | 8.17 | |
Acceleron Pharma | 2.5 | $23M | 686k | 33.98 | |
Spectranetics Corporation | 2.2 | $21M | 1.1M | 18.71 | |
Flexion Therapeutics | 1.5 | $14M | 950k | 14.97 | |
Merus N V (MRUS) | 1.2 | $11M | 1.4M | 7.99 | |
Invuity | 1.1 | $10M | 1.1M | 9.53 | |
Nabriva Therapeutics | 0.8 | $7.9M | 1.1M | 7.50 | |
Wright Medical Group Rtsn V | 0.6 | $5.8M | 4.6M | 1.26 | |
Htg Molecular Diagnostics | 0.4 | $3.5M | 1.3M | 2.72 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $753k | 128k | 5.90 | |
Tokai Pharmaceuticals | 0.1 | $711k | 129k | 5.51 |